Researchers are exploring various strategies to target tumor heterogeneity, including combination therapies that target multiple pathways simultaneously. Another promising approach is adaptive therapy, which adjusts treatment based on the tumor's response, aiming to maintain a stable tumor size rather than attempting complete eradication, which often leads to resistance.
